AI Summary & Key Takeaways
AI InsightIn present study, three cases were presented with the literature, which had detected spontaneous hemothorax due to the anticoagulant therapy during the warfarin therapy.
📌 3 Key Takeaways
Abstract
Bleeding is the most important complication of the anticoagulant therapy. The annual risk of bleeding in patients taking warfarin such as; fatal episode is approximately 1%, major episode is 6.5%, and minor bleeding is 21.8%. A small number of hemothorax cases that formed due to anticoagulant therapy, have been reported in the literature. Shock and mortality may be developed in severe bleeding. Hematoma and trapped lung may be occurred, if hemothorax not adequately discharge. When the hemothorax is seen, anticoagulant therapy should be terminated immediately and pleural range to be discharged. In present study, three cases were presented with the literature, which had detected spontaneous hemothorax due to the anticoagulant therapy during the warfarin therapy.
Özet
Antikoagülan tedavinin en önemli komplikasyonu kanamadır. Warfarin alan hastalarda yıllık kanama riski; fatal epizod yaklaşık %1, major epizod %6.5, minör kanama ise %21.8'dir. Literatürde antikoagülan tedaviye bağlı az sayıda spontan hemotoraks olgusu bildirilmiştir. Kanama şiddetli ise şok ve mortalite gelişebilir. Hemotoraks yeterli şekilde boşaltılmazsa hematom ve hapsolmuş akciğer oluşumu riski taşımaktadır. Hemotoraks görüldüğünde antikoagülan tedavi hemen sonlandırılmalı ve plevral aralık boşaltılmalıdır. Bu çalışmada warfarin tedavisine bağlı üç olguda gelişen spontan hemotoraks olgusu literatür bilgileri ışığında sunuldu.